Exploratory Subgroup And Biomarker Analyses Of Acelera Breast Cancer: Phase Ii Study Of Giredestrant (Gdc-9545) Vs Physician'S Choice Of Endocrine Therapy For Previously Treated, Estrogen Receptor+, Her2- Advanced Breast Cancer
Giredestrant
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Exploratory Subgroup And Biomarker Analyses Of Acelera Breast Cancer: Phase Ii Study Of Giredestrant (Gdc-9545) Vs Physician'S Choice Of Endocrine Therapy For Previously Treated, Estrogen Receptor+, Her2- Advanced Breast Cancer ### Output: Giredestrant